Cervical squamous cell carcinoma
MONDO:0006143A squamous cell carcinoma arising from the cervical epithelium. It usually evolves from a precancerous cervical lesion. Increased numbers of sexual partners and human papillomavirus (HPV) infection are risk factors for cervical squamous cell carcinoma. The following histologic patterns have been described: conventional squamous cell carcinoma, papillary squamous cell carcinoma, transitional cell carcinoma, lymphoepithelioma-like carcinoma, verrucous carcinoma, condylomatous carcinoma and spindle cell carcinoma. Survival is most closely related to the stage of disease at the time of diagnosis.
Also known as: cervical squamous cell cancer, cervical squamous cell carcinoma, cervix squamous cell carcinoma, cervix uteri squamous cell carcinoma, squamous cell carcinoma of cervix, squamous cell carcinoma of cervix uteri, squamous cell carcinoma of the cervix, squamous cell carcinoma of the cervix uteri
2875 clinical trials for this condition and its sub-types, 36 tagged with Cervical squamous cell carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Cervical squamous cell carcinoma
-
Cervical adenosquamous carcinoma 16 trials
1 sub-type
-
Cervical basaloid carcinoma 0 trials
-
Cervical verrucous carcinoma 0 trials
-
New drug cocktail aims to stop cervical cancer return
Disease control Not yet recruitingThis phase II trial tests whether adding pembrolizumab and lenvatinib to standard chemoradiation and brachytherapy can improve outcomes for adults with high-risk locally advanced cervical cancer. About 87 participants will receive the drug combination and be followed for two year…
Phase 2 • Sponsor: Prof. Dr. Remi A. Nout • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could less radiation be better for cervical cancer?
Disease control Not yet recruitingThis study tests whether shrinking the radiation target area after chemotherapy can safely control stage IIb cervical cancer. Sixty participants will receive induction chemo followed by radiation that covers only the uterus, nearby tissues, and a small margin below the tumor. The…
Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Chlorophyll-Based supplement may ease radiation damage in cervical cancer patients
Symptom relief Not yet recruitingThis phase 3 trial tests whether a daily dose of sodium-copper-chlorophyllin, a chlorophyll derivative, can reduce long-term bladder and bowel side effects from radiation therapy in 316 women with locally advanced cervical cancer. Participants take the supplement for 3 months aft…
Phase 3 • Sponsor: Tata Memorial Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC